Survival benefit associated with liver transplantation for hepatocellular carcinoma based on tumor burden scores at listing

Higher TBS during listing correlates with greater LT benefits for patients with unresectable HCC within UNOS criteria. We conclude that organ allocation policies in the United States should prioritize patients with high TBS due to their increased risk of dropout and comparable post-transplant survival when compared to patients with less advanced tumors.

Authors

Institutions

Publication Details

Journal
Hepatology Communications
Published
2025-01-01
DOI
https://doi.org/10.1097/hc9.0000000000000619
Citations
4
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
5.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Survival benefit associated with liver transplantation for hepatocellular carcinoma based on tumor burden scores at listing

Shahid M. Malik, Naudia Jonassaint, Stalin Dharmayan, Ramon Bataller Alberola et al.
4 citations
Hepatology Communications
Hepatocellular Carcinoma Treatment and Prognosis
5.29
article

Survival benefit associated with liver transplantation for hepatocellular carcinoma based on tumor burden scores at listing

Shahid M. Malik, Naudia Jonassaint, Stalin Dharmayan, Ramon Bataller Alberola, Samer Tohme, Andrew Crane, Subhashini Ayloo, Ruy J. Cruz, Liuhua Shi, Vrishketan Sethi, David A. Geller, Abhinav Humar, Vikraman Gunabushanam, Jaideep Behari, Mengyang Di, Amit D. Tevar, Christof Kaltenmeier, Andrés Duarte‐Rojo, Dempsey L. Hughes, Colin Powers, Michele Molinari, Yao Xiao, Xingyu Zhang, Wei Zhang, Hao Liu, Xingjie Li, Xixi Wang, Hang Lee, Christopher Hughes
article en
4 citations

Abstract

Higher TBS during listing correlates with greater LT benefits for patients with unresectable HCC within UNOS criteria. We conclude that organ allocation policies in the United States should prioritize patients with high TBS due to their increased risk of dropout and comparable post-transplant survival when compared to patients with less advanced tumors.

Hepatology CommunicationsVol. 9(1)
University of Arkansas at Little Rock (US), Northwestern University (US), Brigham and Women's Hospital (US), Harvard University (US), Emory University (US), University of Washington (US), Brown University (US), Massachusetts General Hospital (US), Fred Hutch Cancer Center (US), Hospital Clínic de Barcelona (ES), University of Pittsburgh Medical Center (US), Mayo Clinic in Florida (US), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
Good health and well-being
Openalex Percentile: Top 5%
Hepatocellular Carcinoma Treatment and Prognosis
5.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.